|
|||||||||||||||||||||
We’re talking about the New Vice President, Client Management & Business Development at MedTurn- Jennifer Mauldin. Jennifer is certainly a veteran when it comes to the Inmar organization, the parent company of Carolina Logistics and MedTurn. She has been a part of Inmar for over 15 years serving in various sales, service, operations and executive management positions. She is also currently the President of Carolina Services, where one of Carolina’s services is Prism, a billing and reconciliation service for third party pharmacy receivables. Her pharmacy experience with Prism is a perfect fit with the MedTurn organization. By utilizing the experience that Jennifer has gained through Prism, there are huge opportunities to create additional value for clients of MedTurn that can further optimize the pharmacist’s time and capital assets. One of Jennifer’s key beliefs is that outsourcing can be a positive experience for our clients. She has watched the evolution of business outsourcing through her career at Inmar. First as companies’ outsourced coupon processing to most recently as pharmacies have outsourced receivables management in efforts to improve the productivity behind the counter so that pharmacists and technicians can have more time to focus on the customer. She has an in-depth understanding that the last thing that a pharmacy wants to do is to spend time on administrative work. “Our goal is to help our clients stay focused on their core, strategic business, said Jennifer. We do this by becoming an extension of our clients, aligning with their goals, and helping them be more successful by handling the non-core functions of their business.” Note: In January 2004, Jennifer was voted as a “Rising Star” by the trade publication Chain Store Age. She was recognized in a special feature article 40 under 40 Rising Stars. Click here to read the article.
At the recent NACDS Supply Chain & Logistics Conference, the topic of pedigree was discussed in detail. The number of states that are implementing State Pedigree Legislation is continuing to increase. To date eleven states have passed Pedigree Legislation and another three have introduced the Pedigree Legislation. The most discussion centered on the recent Florida and California pedigree legislation that passed. Both of these require immediate action. While samples were not included in these pedigree requirements, all other goods including returns must follow these newly passed legislations. Click here for a chart of the 2005-2006 State Pedigree Legislation. Click here for a comparison of the Florida and California Pedigree Comparison. What is pedigree anyway?
The data content of the pedigree must include source, transaction, ownership and certification of transaction authenticity information. The requirements don’t stop with data collection or the “initiate” step, it also includes steps to authenticate, validate, and certify. This includes actually signing to verify that all steps have been completed. The physical product must be matched against the documents and quarantined if any differences. The FDA Counterfeit Drug Task Force is preparing a report scheduled to be made public in May. One thing is for certain, the State Pedigree Legislation will only to continue to increase. The variability by state will cause additional administrative tasks to manage the different requirements. Many expressed the need for Federal legislation to improve consistency and the ability to manage. However, no one seemed to know if this would happen in the near future. MedTurn systems capture lot code information which helps with tracking of pedigree requirements. Source: NACDS Supply Chain & Logistics presentation by Bruce Harder, Verisign.
One issue that is slowing the implementation is unresolved business and regulatory issues. This issue has many, many components that range from technology to data sharing. At a FDA Public Workshop held last Fall, the FDA indicated that they were not happy with the standards development process. This led to a Town Hall meeting in February with a panel format to address many of the key issues facing adoption of RFID and the creation of an E-Pedigree. Copies of presentations from this meeting are available at www.fda.gov/rfidmeeting.html. Below is a summary of what was heard at the FDA Public Hearing:
A Task Force Report is expected in May 2006. In the meantime, other industry initiatives have been started. McKesson & Accenture started a JumpStart 1 called On Track. The goals of the program are to:
For more information about RFID in healthcare, contact Steve Perlowski. * Source: NACDS Supply Chain & Logistics Presentation- “What’s Next with RFID in Healthcare? By Steve Perlowski
For more information on the conference visit http://www.healthcaredistribution.org/meetings/distribution.asp
|
|||||||||||||||||||||